Intralesional Chemotherapy (IC): Cisplatin + Epinephrine

The purpose of this study is to determine the effects, good and bad, of injecting chemotherapy into recurrent laryngeal squamous cell carcinoma (SCC) tumors.

Trial Details

NCT ID
NCT07392580
Phase
PHASE2
Sponsor
University of Miami
Status
RECRUITING
Cancer Type
Head and Neck Cancer
Interventions
  • Cisplatin
  • Epinephrine injection
  • Laryngeal Biopsy
  • Endoscopic Surgery
Locations (sample)
  • Miami, Florida, United States|25.77427,-80.19366

Key Eligibility Criteria

  • Men and women 18 years and older.
  • Previously treated for laryngeal SCC with radiation.
  • Must have biopsy-proven recurrent cancer requiring surgical management. Note: if participants do not have an archived tissue sample available for r…
  • Participants must be willing to undergo 3 weekly cycles of IC under local anesthesia prior to surgery.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Head and Neck Cancer Trials on Trialify →